prescription drugs

Lawmakers Go Down To Wire On Health Care

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

The Oregon Legislature ended its session on Sunday after a marathon weekend in which it passed several health care bills, including one that went down to the wire.

Lower Drug Prices Are ‘Very Feasible’ In Oregon, Advocate says

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

Drugmakers Blamed for Blocking Generics Have Jacked Up Prices , Cost U.S. Billions

An analysis shows that drug companies that may have worked delay the entrance of cheaper competitors onto the market, which resulted in higher prices and cost taxpayers more money over time.

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis has found.

Pages

Subscribe to prescription drugs